Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemical Neurolysis vs Radiofrequency Ablation for Knee Osteoarthritis Pain
NCT06798038Phase 1Not yet recruiting
- Sponsor
- Tanta University
- Start
- Mar 2025
- Primary completion
- Feb 2027
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of ethanol and phenol in osteoarthritis (OA) (3 arms), sponsored by Tanta University. Primary endpoint: Assessment of Pain Intensity Using 10-point Numerical Rating Scale (NRS-10) at 1 year. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
ethanolphenol
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06798038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06798038.